World Journal of
Pharmaceutical and Life Sciences

( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical and Life Sciences
An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)
World Journal of Pharmaceutical and Life Sciences (WJPLS) has indexed with various reputed international bodies like : Google Scholar, Index Copernicus, Indian Science Publications, SOCOLAR, China, Cosmos Impact Factor, Research Bible, Fuchu, Tokyo. JAPAN, Scientific Indexing Services (SIS), Jour Informatics (Under Process), UDLedge Science Citation Index, Global Impact Factor (In Process), International Impact Factor Services, International Scientific Indexing, UAE, International Society for Research Activity (ISRA) Journal Impact Factor (JIF), Science Library Index, Dubai, United Arab Emirates, International Innovative Journal Impact Factor (IIJIF), Scientific Journal Impact Factor (SJIF), Eurasian Scientific Journal Index (ESJI), Indian citation Index (ICI), IFSIJ Measure of Journal Quality, International Scientific Indexing, UAE (ISI), Web of Science Group (Under Process), Directory of Research Journals Indexing, 



Mohammed Safi Ur-Rahman, Syed Muneb Ahmed, Govinda Nayak, Juzer Sabuwala and S. P. Srinivas Nayak*


Hypertension is an important risk factor for cardiovascular morbidity and mortality, particularly in the elderly. It is defined as persistently elevated arterial blood pressure(BP). Hypertension is directly responsible for 57% of all stroke deaths and 24% of all coronary heart disease (CHD) deaths in India. Both SBP and DBP increase with age. In elderly persons there are specific underlying mechanisms of HTN, including mechanical hemodynamic changes, arterial stiffness, neurohormonal and autonomic dysregulation, and the aging kidney. The goals and strategies for treating hypertension in the elderly population are different from, and more challenging than, in younger patients. Lifestyle modification is effective in this population, but it is difficult to maintain There is often a debate about which antihypertensive drug class should be used first in elderly patients with hypertension. Combination of low dose diuretic (chlorthalidone) and a beta blocker(Atenolol) appears to be suitable first line therapy in vast majority of elderly hypertensive patients, even CCB‘s(Amlodipine) can be substituted for Atenolol. Complex and multiple drug regimes should be avoided in elderly patients as they may be confusing.

[Full Text Article]


World Journal of Pharmaceutical and life sciences Will give best paper award in every issue in the from of money along with certificate to promote research .

Best Article of current issue

Download Article : Click here